Erectile Dysfunction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Erectile Dysfunction stocks.

Erectile Dysfunction Stocks Recent News

Date Stock Title
May 17 PFE 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17 LLY 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17 LLY Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
May 17 LLY Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
May 17 LLY Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs
May 17 PFE Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield
May 16 LLY 3 Stocks to Buy Following Positive Earnings Results
May 16 PFE Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16 LLY 3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
May 16 LLY Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
May 16 PFE 2 Top Growth Stocks Down 24% and 50% to Buy With $100
May 16 LLY Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
May 16 LLY Lilly’s once-weekly insulin matches daily shots in late-stage tests
May 16 LLY Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
May 16 LLY Eli Lilly once-weekly insulin hits main goal in late-stage trials
May 16 LLY These 2 No-Brainer Growth Stocks Are Breaking New Ground
May 16 LLY UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies
May 16 LLY With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
May 16 PFE Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16 PFE Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report
Erectile Dysfunction

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
A physical cause can be identified in about 80% of cases. These include cardiovascular disease, diabetes mellitus, neurological problems such as following prostatectomy, hypogonadism, and drug side effects. Psychological impotence is where erection or penetration fails due to thoughts or feelings; this is somewhat less frequent, in the order of about 10% of cases. In psychological impotence, there is a strong response to placebo treatment.
Treatment involves addressing the underlying causes, lifestyle modifications, and addressing psychosocial issues. In many cases, a trial of pharmacological therapy with a PDE5 inhibitor, such as sildenafil, can be attempted. In some cases, treatment can involve inserting prostaglandin tablets into the urethra, injecting smooth muscle relaxants and vasodilators into the penis, a penile prosthesis, a penis pump, or vascular reconstructive surgery. It is the most common sexual problem in men.

Browse All Tags